Literature DB >> 29855780

A pulmonary embolism response team (PERT) approach: initial experience from the Cleveland Clinic.

Jamal H Mahar1, Ihab Haddadin2, Divyajot Sadana3, Abishek Gadre4, Natalie Evans5, Deborah Hornacek5, Natalia Fendrikova Mahlay5, Marcelo Gomes5, Douglas Joseph5, Maya Serhal5, Michael Zhen-Yu Tong5, Seth R Bauer6, Michael Militello6, Bernard Silver7, Mehdi Shishehbor8, John R Bartholomew5, Gustavo A Heresi9.   

Abstract

Management of intermediate and high risk acute pulmonary embolism (PE) is challenging. The role of multidisciplinary teams for the care of these patients is emerging. Herein, we report our experience with a pulmonary embolism response team (PERT). We conducted a retrospective chart review on all patients admitted to the Cleveland Clinic main campus who required activation of the (PERT) from October 1, 2014 to September 1, 2016. We extracted data pertaining to clinical presentation, bleeding complications, and pre- and post-discharge imaging. Patients were classified as low, intermediate or high risk PE. Descriptive and continuous variables were collected and analyzed. There were 134 PERT activations. PE was confirmed by CT-PA in 118 patients. Fifteen (13%) patients were classified as low risk, 80 (68%) intermediate risk PE and 23 (19%) high risk PE. Fourteen (12%) patients were treated with catheter directed rtPA, 6 (5%) received full dose (100 mg rtPA), 16 (13%) received systemic half-dose (50 mg rtPA), 6 (5%) underwent a surgical embolectomy and 4 (3%) underwent mechanical thrombectomy. 65 (55%) patients received anticoagulation only, and 8 (7%) patients were managed conservatively without any anticoagulation or advanced therapy. 11 (9%) patients died while during the hospitalization. Fourteen patients had major bleeding events. There were no bleeding events among patients who received systemic low dose or full dose rtPA. A multidisciplinary approach to cases of intermediate risk and high risk PE can be implemented successfully. We saw a relatively low rate of bleeding events with use of rtPA.

Entities:  

Keywords:  Anticoagulation; PERT; Pulmonary embolism; Thrombolysis

Mesh:

Substances:

Year:  2018        PMID: 29855780     DOI: 10.1007/s11239-018-1686-2

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  14 in total

1.  Surgical Pulmonary Embolectomy.

Authors:  Timothy J Poterucha; Brian Bergmark; Sary Aranki; Tsuyoshi Kaneko; Gregory Piazza
Journal:  Circulation       Date:  2015-09-22       Impact factor: 29.690

2.  Risk factors associated with bleeding after alteplase administration for pulmonary embolism: a case-control study.

Authors:  Garrett M Curtis; Simon W Lam; Anita J Reddy; Seth R Bauer
Journal:  Pharmacotherapy       Date:  2014-05-22       Impact factor: 4.705

3.  Thrombolysis in submassive pulmonary embolism: Finding the balance.

Authors:  Carlos L Alviar; Gustavo A Heresi
Journal:  Cleve Clin J Med       Date:  2016-12       Impact factor: 2.321

4.  Moderate pulmonary embolism treated with thrombolysis (from the "MOPETT" Trial).

Authors:  Mohsen Sharifi; Curt Bay; Laura Skrocki; Farnoosh Rahimi; Mahshid Mehdipour
Journal:  Am J Cardiol       Date:  2012-10-24       Impact factor: 2.778

5.  Outpatient versus inpatient treatment for patients with acute pulmonary embolism: an international, open-label, randomised, non-inferiority trial.

Authors:  Drahomir Aujesky; Pierre-Marie Roy; Franck Verschuren; Marc Righini; Joseph Osterwalder; Michael Egloff; Bertrand Renaud; Peter Verhamme; Roslyn A Stone; Catherine Legall; Olivier Sanchez; Nathan A Pugh; Alfred N'gako; Jacques Cornuz; Olivier Hugli; Hans-Jürg Beer; Arnaud Perrier; Michael J Fine; Donald M Yealy
Journal:  Lancet       Date:  2011-06-22       Impact factor: 79.321

6.  Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients.

Authors:  S Schulman; C Kearon
Journal:  J Thromb Haemost       Date:  2005-04       Impact factor: 5.824

7.  Time trends in pulmonary embolism in the United States: evidence of overdiagnosis.

Authors:  Renda Soylemez Wiener; Lisa M Schwartz; Steven Woloshin
Journal:  Arch Intern Med       Date:  2011-05-09

8.  Nuts and bolts of running a pulmonary embolism response team: results from an organizational survey of the National PERT™ Consortium members.

Authors:  Geoffrey Barnes; Jay Giri; D Mark Courtney; Soophia Naydenov; Todd Wood; Rachel Rosovsky; Kenneth Rosenfield; Christopher Kabrhel
Journal:  Hosp Pract (1995)       Date:  2017-03-31

9.  Hospital costs of acute pulmonary embolism.

Authors:  John Fanikos; Amanda Rao; Andrew C Seger; Danielle Carter; Gregory Piazza; Samuel Z Goldhaber
Journal:  Am J Med       Date:  2013-02       Impact factor: 4.965

10.  A Multidisciplinary Pulmonary Embolism Response Team: Initial 30-Month Experience With a Novel Approach to Delivery of Care to Patients With Submassive and Massive Pulmonary Embolism.

Authors:  Christopher Kabrhel; Rachel Rosovsky; Richard Channick; Michael R Jaff; Ido Weinberg; Thoralf Sundt; David M Dudzinski; Josanna Rodriguez-Lopez; Blair A Parry; Savanah Harshbarger; Yuchiao Chang; Kenneth Rosenfield
Journal:  Chest       Date:  2016-03-19       Impact factor: 9.410

View more
  8 in total

1.  Right ventricular dysfunction is superior and sufficient for risk stratification by a pulmonary embolism response team.

Authors:  Yu Lin Chen; Colin Wright; Anthony P Pietropaoli; Ayman Elbadawi; Joseph Delehanty; Bryan Barrus; Igor Gosev; David Trawick; Dhwani Patel; Scott J Cameron
Journal:  J Thromb Thrombolysis       Date:  2020-01       Impact factor: 2.300

2.  Surgical embolectomy in a 34-week pregnant woman with high risk pulmonary embolism and haemodynamic instability.

Authors:  Giulia Maj; Nicola Strobelt; Andrea Audo; Anna Maria Arena; Giovanni Parodi; Vittorio Aguggia; Massimo Serra; Maria Giribaldi; Ermelinda Martuscelli; Fabrizio Racca
Journal:  Ann Card Anaesth       Date:  2022 Apr-Jun

3.  Adoption of a dedicated multidisciplinary team is associated with improved survival in acute pulmonary embolism.

Authors:  Lukasz A Myc; Jigna N Solanki; Andrew J Barros; Nebil Nuradin; Matthew G Nevulis; Kranthikiran Earasi; Emily D Richardson; Shawn C Tsutsui; Kyle B Enfield; Nicholas R Teman; Ziv J Haskal; Sula Mazimba; Jamie L W Kennedy; Andrew D Mihalek; Aditya M Sharma; Alexandra Kadl
Journal:  Respir Res       Date:  2020-06-22

4.  Rationale for catheter-based therapies in acute pulmonary embolism.

Authors:  M A de Winter; G J Vlachojannis; D Ruigrok; M Nijkeuter; A O Kraaijeveld
Journal:  Eur Heart J Suppl       Date:  2019-11-21       Impact factor: 1.803

Review 5.  Inpatient Management of Pulmonary Embolism: Clinical Characteristics and Mortality in a High-Volume Tertiary Care Center.

Authors:  Harsha V Mudrakola; Sean M Caples; Robert J Hyde; Robert D McBane Ii; Sumera R Ahmad
Journal:  J Thromb Thrombolysis       Date:  2022-01-13       Impact factor: 2.300

6.  Pulmonary embolism response team (PERT) implementation and its clinical value across countries: a scoping review and meta-analysis.

Authors:  Lukas Hobohm; Ioannis T Farmakis; Karsten Keller; Barbara Scibior; Anna C Mavromanoli; Ingo Sagoschen; Thomas Münzel; Ingo Ahrens; Stavros Konstantinides
Journal:  Clin Res Cardiol       Date:  2022-08-17       Impact factor: 6.138

7.  Characteristics and Outcomes of Patients Consulted by a Multidisciplinary Pulmonary Embolism Response Team: 5-Year Experience.

Authors:  Arkadiusz Pietrasik; Aleksandra Gąsecka; Paweł Kurzyna; Katarzyna Wrona; Szymon Darocha; Marta Banaszkiewicz; Dariusz Zieliński; Dominika Zajkowska; Julia Maria Smyk; Dominika Rymaszewska; Karolina Jasińska; Marcin Wasilewski; Rafał Wolański; Grzegorz Procyk; Piotr Szwed; Michał Florczyk; Krzysztof Wróbel; Marcin Grabowski; Adam Torbicki; Marcin Kurzyna
Journal:  J Clin Med       Date:  2022-06-30       Impact factor: 4.964

8.  Role of Pulmonary Embolism Response Team in patients with intermediate- and high-risk pulmonary embolism: a concise review and preliminary experience from China.

Authors:  Ying Liang; Shao-Ping Nie; Xiao Wang; Ashley Thomas; Elizabeth Thompson; Guan-Qi Zhao; Jing Han; Jing Wang; Mark J D Griffiths
Journal:  J Geriatr Cardiol       Date:  2020-08       Impact factor: 3.327

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.